Biopsy needles are essential medical devices used for the diagnosis of various diseases, including cancer. They are commonly used in biopsy procedures to extract tissue samples from the body. The global biopsy needle market has witnessed substantial growth in recent years due to the increasing prevalence of cancer, technological advancements in biopsy needle products, and rising demand for minimally invasive procedures. According to a report by Market Research Future (MRFR), the global biopsy needle market is expected to grow at a CAGR of 7.5% during the forecast period (2021-2028).
One of the major factors driving the growth of the global biopsy needle market is the increasing prevalence of cancer. According to the World Health Organization (WHO), cancer is the second leading cause of death globally, with an estimated 9.6 million deaths in 2018. This has led to a rise in the demand for biopsy needles, as they are an essential tool for cancer diagnosis.
Moreover, technological advancements in biopsy needle products have also contributed to the growth of the global biopsy needle market. The development of new and innovative biopsy needle products, such as vacuum-assisted biopsy (VAB) needles and core biopsy needles, has improved the accuracy of biopsy procedures and reduced patient discomfort.
Another significant trend in the global biopsy needle market is the increasing demand for minimally invasive procedures. Minimally invasive procedures are less painful and require a shorter recovery time than traditional surgery, making them more attractive to patients. Biopsy needles are an essential tool for minimally invasive procedures, as they allow doctors to extract tissue samples without the need for large incisions.
The global biopsy needle market can be segmented based on product type, application, end-user, and region. Based on product type, the market can be divided into core biopsy needles, fine-needle aspiration biopsy needles, vacuum-assisted biopsy needles, and others. Core biopsy needles are expected to hold the largest share of the market, owing to their high accuracy and reliability.
Based on application, the global biopsy needle market can be segmented into breast biopsy, lung biopsy, prostate biopsy, liver biopsy, and others. The breast biopsy segment is expected to hold the largest share of the market, due to the high prevalence of breast cancer.
Based on end-user, the market can be divided into hospitals, diagnostic centers, and others. The hospital segment is expected to hold the largest share of the market, due to the high number of biopsy procedures conducted in hospitals.
Geographically, the global biopsy needle market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to hold the largest share of the market, due to the high prevalence of cancer in the region and the presence of advanced healthcare infrastructure. Asia Pacific is expected to witness the highest growth rate during the forecast period, owing to the increasing demand for biopsy needle products in emerging economies such as China and India.
In conclusion, the global biopsy needle market is expected to witness significant growth during the forecast period, owing to the increasing prevalence of cancer, technological advancements in biopsy needle products, and rising demand for minimally invasive procedures. Core biopsy needles, breast biopsy, and hospitals are expected to hold the largest share of the market. North America is expected to hold the largest share of the market, while Asia Pacific is expected to witness the highest growth rate. As the demand for biopsy needle products continues to grow, manufacturers are likely to invest in research and development to develop new and innovative products, further fueling the growth of the global biopsy needle market.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Brite View Research journalist was involved in the writing and production of this article.